No Data
Analysts Are Bullish on Top Healthcare Stocks: Biomea Fusion (BMEA), Day One Biopharmaceuticals (DAWN)
Day One Biopharmaceuticals Capitalizes on Priority Review Sale
Express News | Day One Announces Sale of Priority Review Voucher for $108 Million
Viking, CRISPR, Intellia Among Potential M&A Targets: Wells Fargo
BrightSpring Health Services Says Onco360 Selected as Pharmacy Partner for Ojemda
BrightSpring Health Services (BTSG) said Monday its oncology pharmacy Onco360 has partnered with Day One Biopharmaceuticals (DAWN) to become a specialty provider of Ojemda, a treatment for children wi
Day One Biopharmaceuticals(DAWN.US) Officer Sells US$126.59K in Common Stock
$Day One Biopharmaceuticals(DAWN.US)$ Officer Bender Jeremy sold 7,873 shares of common stock on May 16, 2024 at an average price of $16.0787 for a total value of $126.59K.Source: Announcement What is